# Targan

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/targan

- Industry: Agribusiness
- Headquarters: Raleigh, US
- Website: www.targan.com/
- Total disclosed funding: $43M
- Latest round: Series C (May 24, 2022)
- Investors on record: 5

## About

Targan Inc. fomerly known as Applied LifeSciences & Systems is a US-based company specializing in advanced AgTech solutions for improving health and productivity in the poultry, livestock, and aquaculture sectors.Founded in 2015 in Morrisville, US, Targan Inc. focuses on innovative AgTech solutions. The company was founded by Ramin Karimpour, who has experience in the industry. In December 2025, Targan Inc. raised USD 100 million in venture debt from Symbiotic Capital. Targan specializes in advanced animal AgTech solutions aimed at improving animal health and productivity within the poultry, livestock, and aquaculture industries. Their flagship products include the WingScan automated feather sexing system, employing artificial intelligence and machine learning for accurate chick sex identification at hatcheries, optimizing poultry production. They also offer a high-speed imaging vaccination system for administering ocular vaccines to individual birds, enhancing flock health. Targan's products serve a diverse clientele across North America, Europe, and Asia.Targan generates revenue through sales of its products and services in the agricultural sector. Their pricing is based on tailored contracts to meet customer needs. Key offerings like the WingScan system and vaccination technology are integral to their strategy, likely resulting in long-term agreements with clients due to the proprietary nature of their technologies. The company will use the December 2025 funding to support continued growth, accelerate commercial deployment of WingScan, replace its previous senior lender, and provide liquidity and flexibility to bring new technologies to market.

## Funding rounds

- Series C, May 24, 2022, $28M — NovaQuest Capital Management, Mountain Group Partners, Oval Park Capital, Merck Animal Health Ventures
- Series B, May 12, 2021, $7M — Mountain Group Partners, Oval Park Capital, Merck Animal Health Ventures
- Series A, Mar 22, 2019, $8M — Mountain Group Partners, Merck Animal Health, Oval Park Capital

## Investors

- Mountain Group Partners (https://capitalatlas.ai/funds/mountain-group-partners) — Series A, Series B, Series C
- Merck Animal Health — Series A
- Oval Park Capital (https://capitalatlas.ai/funds/oval-park-capital) — Series A, Series B, Series C
- Merck Animal Health Ventures (https://capitalatlas.ai/funds/merck-animal-health-ventures) — Series B, Series C
- NovaQuest Capital Management (https://capitalatlas.ai/funds/novaquest-capital-management) — Series C